A review of the molecular mechanisms of hyperglycemia-induced free radical generation leading to oxidative stress

Journal of Cellular Physiology

Volumn 234, Issue 2, 2019, Pages 1300-1312

  Yaribeygi, Habib ^a   Atkin, Stephen L ^b   Sahebkar, Amirhossein ^c,d,e  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b WEILL CORNELL MEDICAL COLLEGE   (Qatar)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

cytochrome P450 enzyme system; diabetes complications; free radicals; hyperglycemia; NADPH oxidase; oxidative stress

Indexed keywords

ANTIDIABETIC AGENT; CYTOCHROME P450; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FREE RADICAL; GLUCOSE; HEXOSAMINE; LIPOXYGENASE; MYELOPEROXIDASE; POLYOL; PROSTAGLANDIN SYNTHASE; PROTEIN KINASE C; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; XANTHINE OXIDASE; ANTIOXIDANT;

ANTIOXIDANT ACTIVITY; AUTOOXIDATION; DIABETES MELLITUS; ENZYME ACTIVATION; GLUCOSE METABOLISM; GLYCATION; HUMAN; HYPERGLYCEMIA; LIPID PEROXIDATION; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; BLOOD; DIABETIC COMPLICATION; DRUG EFFECT; ENERGY METABOLISM; GLUCOSE BLOOD LEVEL; METABOLISM; PATHOLOGY;

ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; DIABETES COMPLICATIONS; ENERGY METABOLISM; FREE RADICALS; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; MITOCHONDRIA; OXIDATIVE STRESS; SIGNAL TRANSDUCTION;

EID: 85052381401     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.27164     Document Type: Review

References (145)

1. Ardolino, M., Zingoni, A., Cerboni, C., Cecere, F., Soriani, A., Iannitto, M. L., & Santoni, A. (2011). DNAM-1 ligand expression on Ag-stimulated T lymphocytes is mediated by ROS-dependent activation of DNA-damage response: Relevance for NK–T cell interaction. Blood, 117(18), 4778–4786.
2. Asgary, S., Rafieiankopaei, M., Sahebkar, A., Shamsi, F., & Goli-malekabadi, N. (2016). Anti-hyperglycemic and anti-hyperlipidemic effects of Vaccinium myrtillus fruit in experimentally induced diabetes (antidiabetic effect of Vaccinium myrtillus fruit). Journal of the Science of Food and Agriculture, 96(3), 764–768.
3. Asgary, S., Rafieian-Kopaei, M., Shamsi, F., Najafi, S., & Sahebkar, A. (2014). Biochemical and histopathological study of the anti-hyperglycemic and anti-hyperlipidemic effects of cornelian cherry (Cornus mas L.) in alloxan-induced diabetic rats. Journal of Complementary and Integrative Medicine, 11(2), 63–69.
4. Asmat, U., Abad, K., & Ismail, K. (2016). Diabetes mellitus and oxidative stress—a concise review. Saudi Pharmaceutical Journal, 24(5), 547–553.
5. Babior, B. M. (1999). NADPH oxidase: An update. Blood, 93(5), 1464–1476.
6. Bansal, S., Liu, C.-P., Sepuri, N. B. V., Anandatheerthavarada, H. K., Selvaraj, V., Hoek, J., … Avadhani, N. G. (2010). Mitochondria-targeted cytochrome P450 2E1 induces oxidative damage and augments alcohol-mediated oxidative stress. Journal of Biological Chemistry, 285(32), 24609–24619.
7. Basir, S., & Shailey, S. F. (2012). Strengthening of antioxidant defense by Azadirachta indica in alloxan-diabetic rat tissues. Journal of Ayurveda and Integrative Medicine, 3(3), 130.
8. Batchuluun, B., Inoguchi, T., Sonoda, N., Sasaki, S., Inoue, T., Fujimura, Y., … Takayanagi, R. (2014). Metformin and liraglutide ameliorate high glucose-induced oxidative stress via inhibition of PKC-NAD (P) H oxidase pathway in human aortic endothelial cells. Atherosclerosis, 232(1), 156–164.
9. Bich-Hoai, T. T., Marin, A., Dinu, C., Banciu, D., Maria-Luiza, F., & Ristoiu, V. (2010). Hypoxia and high glucose activate tetrodotoxin-resistant Na(+) currents through PKA and PKC. Acta Neurobiologiae Experimentalis, 70(4), 351–361.
10. Blagosklonny, M. V. (2008). Aging: Ros or tor. Cell Cycle, 7(21), 3344–3354.
11. Bogdanov, P., Solà-Adell, C., Hernández, C., García-Ramírez, M., Sampedro, J., Simó-Servat, O., … Simó, R. (2017). Calcium dobesilate prevents the oxidative stress and inflammation induced by diabetes in the retina of db/db mice. Journal of Diabetes and its Complications, 31(10), 1481–1490.
12. Bondoc, F. Y., Bao, Z., Hu, W.-Y., Gonzalez, F. J., Wang, Y., Yang, C. S., & Hong, J.-Y. (1999). Acetone catabolism by cytochrome P450 2E1: Studies with CYP2E1-null mice. Biochemical Pharmacology, 58(3), 461–463.
13. Bonnefont-Rousselot, D., Raji, B., Walrand, S., Gardès-Albert, M., Jore, D., Legrand, A., … Vasson, M. P. (2003). An intracellular modulation of free radical production could contribute to the beneficial effects of metformin towards oxidative stress. Metabolism: Clinical and Experimental, 52(5), 586–589.
14. Boonstra, J., & Post, J. A. (2004). Molecular events associated with reactive oxygen species and cell cycle progression in mammalian cells. Gene, 337, 1–13.
15. Brand, M. D. (2010). The sites and topology of mitochondrial superoxide production. Experimental Gerontology, 45(7), 466–472.
16. Brash, A. R. (1999). Lipoxygenases: Occurrence, functions, catalysis, and acquisition of substrate. Journal of Biological Chemistry, 274(34), 23679–23682.
17. Brown, D. M., Donaldson, K., Borm, P. J., Schins, R. P., Dehnhardt, M., Gilmour, P., … Stone, V. (2004). Calcium and ROS-mediated activation of transcription factors and TNF-α cytokine gene expression in macrophages exposed to ultrafine particles. American Journal of Physiology-Lung Cellular and Molecular Physiology, 286(2), L344–L353.
18. Brownlee, M. (2005). The pathobiology of diabetic complications. Diabetes, 54(6), 1615–1625.
19. Buse, M. G. (2006). Hexosamines, insulin resistance, and the complications of diabetes: Current status. American Journal of Physiology-Endocrinology and Metabolism, 290(1), E1–E8.
20. Bókkon, I. (2012). Recognition of functional roles of free radicals. Current neuropharmacology, 10(4), 287–288.
21. Chakraborty, A., Chowdhury, S., & Bhattacharyya, M. (2011). Effect of metformin on oxidative stress, nitrosative stress and inflammatory biomarkers in type 2 diabetes patients. Diabetes Research and Clinical Practice, 93(1), 56–62.
22. Chatuphonprasert, W., Lao-ong, T., & Jarukamjorn, K. (2014). Improvement of superoxide dismutase and catalase in streptozotocin–nicotinamide-induced type 2-diabetes in mice by berberine and glibenclamide. Pharmaceutical Biology, 52(4), 419–427.
23. Chaudhry, J., Ghosh, N. N., Roy, K., & Chandra, R. (2007). Antihyperglycemic effect of a new thiazolidinedione analogue and its role in ameliorating oxidative stress in alloxan-induced diabetic rats. Life Sciences, 80(12), 1135–1142.
24. Chen, F., Yu, Y., Haigh, S., Johnson, J., Lucas, R., Stepp, D. W., & Fulton, D. J. R. (2014). Regulation of NADPH oxidase 5 by protein kinase C isoforms. PLoS One, 9(2), e88405.
25. Chugh, S. N., Dhawan, R., Kishore, K., Sharma, A., & Chugh, K. (2001). Glibenclamide vs gliclazide in reducing oxidative stress in patients of noninsulin dependent diabetes mellitus—a double blind randomized study. The Journal of the Association of Physicians of India, 49, 803–807.
26. Chung, S. S., Ho, E. C., Lam, K. S., & Chung, S. K. (2003). Contribution of polyol pathway to diabetes-induced oxidative stress. Journal of the American Society of Nephrology, 14(suppl 3), S233–S236.
27. Condorelli, G., Vigliotta, G., Trencia, A., Maitan, M. A., Caruso, M., Miele, C., … Beguinot, F. (2017). Expression of concern. Protein kinase C (PKC)-α activation inhibits PKC-ζ and mediates the action of PED/PEA-15 on glucose transport in the L6 skeletal muscle cells. Diabetes, 2001(50), 1244–1252. https://doi.org/10.2337/diabetes.
28. Cordero-Herrera, I., Martín, M. A., Goya, L., & Ramos, S. (2015). Cocoa flavonoids protect hepatic cells against high-glucose-induced oxidative stress: Relevance of MAPKs. Molecular Nutrition & Food Research, 59(4), 597–609.
29. Craven, P. A., Davidson, C. M., & DeRubertis, F. R. (1990). Increase in diacylglycerol mass in isolated glomeruli by glucose from de novo synthesis of glycerolipids. Diabetes, 39(6), 667–674.
30. Daghigh, F., Alihemmati, A., Karimi, P., Habibi, P., & Ahmadiasl, N. (2017). Genistein preserves the lungs of ovariectomized diabetic rats: Addition to apoptotic and inflammatory markers in the lung. Iranian Journal of Basic Medical Sciences, 20(12), 1312–1317.
31. Dembinska-Kiec, A., Mykkänen, O., Kiec-Wilk, B., & Mykkänen, H. (2008). Antioxidant phytochemicals against type 2 diabetes. British Journal Nutrition 99 E-S1, 1, ES109–ES117.
32. Desco, M.-C., Asensi, M., Marquez, R., Martinez-Valls, J., Vento, M., Pallardo, F. V., … Vina, J. (2002). Xanthine oxidase is involved in free radical production in type 1 diabetes. Diabetes, 51(4), 1118–1124.
33. Eid, A. A., Ford, B. M., Block, K., Kasinath, B. S., Gorin, Y., Ghosh-Choudhury, G., … Abboud, H. E. (2010). AMP-activated protein kinase (AMPK) negatively regulates Nox4-dependent activation of p53 and epithelial cell apoptosis in diabetes. Journal of Biological Chemistry, 285(48), 37503–37512.
34. Evans, J. L., Goldfine, I. D., Maddux, B. A., & Grodsky, G. M. (2003). Are oxidative stress-activated signaling pathways mediators of insulin resistance and β-cell dysfunction? Diabetes, 52(1), 1–8.
35. Fakhruddin, S., Alanazi, W., & Jackson, K. E. (2017). Diabetes-induced reactive oxygen species: Mechanism of their generation and role in renal injury. Journal of Diabetes Research, 2017, 1–30.
36. Feillet-Coudray, C., Fouret, G., Aoun, M., Carillon, J., Sutra, T., Laurent, C., … Coudray, C. (2016). Xanthine oxidase is variably involved in nutritional and physio-pathologic oxidative stress situations. Endocrinology & Diabetes Research, 2013.
37. Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., … Shimomura, I. (2017). Increased oxidative stress in obesity and its impact on metabolic syndrome. The Journal of Clinical Investigation, 114(12), 1752–1761.
38. Gahalain, N., Chaudhary, J., Kumar, A., Sharma, S., & Jain, A. (2011). Lipid peroxidation: An overview. International Journal of Pharmaceutical Sciences and Research, 2(11), 2757.
39. Giacco, F., & Brownlee, M. (2010). Oxidative stress and diabetic complications. Circulation Research, 107(9), 1058–1070.
40. Glasauer, A., & Chandel, N. S. (2013). Ros. Current Biology, 23(3), R100–R102.
41. Glazebrook, J. (2005). Contrasting mechanisms of defense against biotrophic and necrotrophic pathogens. Annual Review of Phytopathology, 43, 205–227.
42. Goldin, A., Beckman, J. A., Schmidt, A. M., & Creager, M. A. (2006). Advanced glycation end products. Circulation, 114(6), 597–605.
43. Goli-Malekabadi, N., Asgary, S., Rashidi, B., Rafieian-Kopaei, M., Ghannadian, M., Hajian, S., & Sahebkar, A. (2014). The protective effects of Ziziphus vulgaris L. fruits on biochemical and histological abnormalities induced by diabetes in rats. Journal of Complementary and Integrative Medicine, 11(3), 171–177.
44. Gopalakrishna, R., & Jaken, S. (2000). Protein kinase C signaling and oxidative stress. Free Radical Biology and Medicine, 28(9), 1349–1361.
45. Grankvist, K., Marklund, S. L., & Täljedal, I. B. (1981). CuZn-superoxide dismutase, Mn-superoxide dismutase, catalase and glutathione peroxidase in pancreatic islets and other tissues in the mouse. Biochemical Journal, 199(2), 393–398.
46. Greene, D. A., Stevens, M. J., Obrosova, I., & Feldman, E. L. (1999). Glucose-induced oxidative stress and programmed cell death in diabetic neuropathy. European Journal of Pharmacology, 375(1), 217–223.
47. Guengerich, F. P. (2015a). Human cytochrome P450 enzymes. In Ortiz de Montellano PR, Editor, Cytochrome P450 (pp. 377–530). New York: Springer.
48. Guengerich, F. P. (2015b). Human cytochrome P450 enzymes. In Ortiz de Montellano PR, Editor, Cytochrome P450 (pp. 523–785). New York: Springer.
49. Hall, J. E. (2015). Guyton and Hall textbook of medical physiology. Amsterdam, The Netherlands: Elsevier Health Sciences.
50. Heitzer, T., Krohn, K., Albers, S., & Meinertz, T. (2000). Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with type II diabetes mellitus. Diabetologia, 43(11), 1435–1438.
51. Helmersson, J., Vessby, B., Larsson, A., & Basu, S. (2004). Association of type 2 diabetes with cyclooxygenase-mediated inflammation and oxidative stress in an elderly population. Circulation, 109(14), 1729–1734.
52. Hendarto, H., Inoguchi, T., Maeda, Y., Ikeda, N., Zheng, J., Takei, R., … Takayanagi, R. (2012). GLP-1 analog liraglutide protects against oxidative stress and albuminuria in streptozotocin-induced diabetic rats via protein kinase A-mediated inhibition of renal NAD (P) H oxidases. Metabolism: Clinical and Experimental, 61(10), 1422–1434.
53. Holguin, F., & Fitzpatrick, A. (2010). Obesity, asthma, and oxidative stress. Journal of Applied Physiology, 108(3), 754–759.
54. Horal, M., Zhang, Z., Stanton, R., Virkamäki, A., & Loeken, M. R. (2004). Activation of the hexosamine pathway causes oxidative stress and abnormal embryo gene expression: Involvement in diabetic teratogenesis. Birth Defects Research Part A: Clinical and Molecular Teratology, 70(8), 519–527.
55. Hosokawa, K., Arai, F., Yoshihara, H., Nakamura, Y., Gomei, Y., Iwasaki, H., … Suda, T. (2007). Function of oxidative stress in the regulation of hematopoietic stem cell-niche interaction. Biochemical and Biophysical Research Communications, 363(3), 578–583.
56. Hunt, J. V., Dean, R. T., & Wolff, S. P. (1988). Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing. Biochemical Journal, 256(1), 205–212.
57. Hägglöf, B., Marklund, S. L., & Holmgren, G. (1983). CuZn superoxide dismutase, Mn superoxide dismutase, catalase and glutathione peroxidase in lymphocytes and erythrocytes in insulin-dependent diabetic children. Acta Endocrinologica, 102(2), 235–239.
58. Igarashi, M., Wakasaki, H., Takahara, N., Ishii, H., Jiang, Z.-Y., Yamauchi, T., … King, G. L. (1999). Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways. Journal of Clinical Investigation, 103(2), 185–195.
59. Kakkar, R., Kalra, J., Mantha, S. V., & Prasad, K. (1995). Lipid peroxidation and activity of antioxidant enzymes in diabetic rats. Molecular and Cellular Biochemistry, 151(2), 113–119.
60. Kakkar, R., Mantha, S. V., Radhi, J., Prasad, K., & Kalra, J. (1998). Increased oxidative stress in rat liver and pancreas during progression of streptozotocin-induced diabetes. Clinical Science, 94(6), 623–632.
61. Kanasaki, K. (2018). The role of renal dipeptidyl peptidase-4 in kidney disease: Renal effects of dipeptidyl peptidase-4 inhibitors with a focus on linagliptin. Clinical Science (London), 132(4), 489–507.
62. Kaneto, H., Xu, G., Song, K.-H., Suzuma, K., Bonner-Weir, S., Sharma, A., & Weir, G. C. (2001). Activation of the hexosamine pathway leads to deterioration of pancreatic β-cell function through the induction of oxidative stress. Journal of Biological Chemistry, 276(33), 31099–31104.
63. Kishida, K. T., & Klann, E. (2007). Sources and targets of reactive oxygen species in synaptic plasticity and memory. Antioxidants & redox signaling, 9(2), 233–244.
64. Kondo, M., Oya-Ito, T., Kumagai, T., Osawa, T., & Uchida, K. (2001). Cyclopentenone prostaglandins as potential inducers of intracellular oxidative stress. Journal of Biological Chemistry, 276(15), 12076–12083.
65. Korshunov, S. S., Skulachev, V. P., & Starkov, A. A. (1997). High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Letters, 416(1), 15–18.
66. Kotchoni, S. O., & Gachomo, E. W. (2006). The reactive oxygen species network pathways: An essential prerequisite for perception of pathogen attack and the acquired disease resistance in plants. Journal of Biosciences, 31(3), 389–404.
67. Kröller-Schön, S., Knorr, M., Hausding, M., Oelze, M., Schuff, A., Schell, R., … Daiber, A. (2012). Glucose-independent improvement of vascular dysfunction in experimental sepsis by dipeptidyl-peptidase 4 inhibition. Cardiovascular Research, 96(1), 140–149.
68. Kuhn, H., Walther, M., & Kuban, R. J. (2002). Mammalian arachidonate 15-lipoxygenases: Structure, function, and biological implications. Prostaglandins & Other Lipid Mediators, 68, 263–290.
69. Lazarevic-Pasti, T., Leskovac, A., & Vasic, V. (2015). Myeloperoxidase inhibitors as potential drugs. Current Drug Metabolism, 16(3), 168–190.
70. Lee, H. J., Lee, D. Y., Mariappan, M. M., Feliers, D., Ghosh-Choudhury, G., Abboud, H. E., … Kasinath, B. S. (2017). Hydrogen sulfide inhibits high glucose-induced NADPH oxidase 4 expression and matrix increase by recruiting inducible nitric oxide synthase in kidney proximal tubular epithelial cells. Journal of Biological Chemistry, 292(14), 5665–5675.
71. Lenzen, S., Drinkgern, J., & Tiedge, M. (1996). Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radical Biology and Medicine, 20(3), 463–466.
72. Liu, J., Wang, C., Liu, F., Lu, Y., & Cheng, J. (2015). Metabonomics revealed xanthine oxidase-induced oxidative stress and inflammation in the pathogenesis of diabetic nephropathy. Analytical and Bioanalytical Chemistry, 407(9), 2569–2579.
73. Liu, K., Paterson, A. J., Chin, E., & Kudlow, J. E. (2000). Glucose stimulates protein modification by O-linked GlcNAc in pancreatic β cells: Linkage of O-linked GlcNAc to β cell death. Proceedings of the National Academy of Sciences, 97(6), 2820–2825.
74. Liu, L., Zuo, Z., Lu, S., Liu, A., & Liu, X. (2017). Naringin attenuates diabetic retinopathy by inhibiting inflammation, oxidative stress and NF-κB activation in Vivo and in Vitro. Iranian Journal of Basic Medical Sciences, 20(7), 814–822.
75. Liu, Y., Fiskum, G., & Schubert, D. (2002). Generation of reactive oxygen species by the mitochondrial electron transport chain. Journal of Neurochemistry, 80(5), 780–787.
76. Lobo, V., Patil, A., Phatak, A., & Chandra, N. (2010). Free radicals, antioxidants and functional foods: Impact on human health. Pharmacognosy Reviews, 4(8), 118.
77. Luo, S., Lei, H., Qin, H., & Xia, Y. (2014). Molecular mechanisms of endothelial NO synthase uncoupling. Current Pharmaceutical Design, 20(22), 3548–3553.
78. Marchi, S., Giorgi, C., Suski, J. M., Agnoletto, C., Bononi, A., Bonora, M., … Pinton, P. (2011). Mitochondria-ros crosstalk in the control of cell death and aging. Journal of Signal Transduction, 2012, 329635.
79. Maritim, A. C., Sanders, R. A., & Watkins, J. B., 3rd. (2003). Diabetes, oxidative stress, and antioxidants: A review. Journal of Biochemical and Molecular Toxicology, 17(1), 24–38.
80. Mathebula, S. D. (2015). Polyol pathway: A possible mechanism of diabetes complications in the eye. African Vision and Eye Health, 74(1), 5.
81. Matsumoto, S., Koshiishi, I., Inoguchi, T., Nawata, H., & Utsumi, H. (2003). Confirmation of superoxide generation via xanthine oxidase in streptozotocin-induced diabetic mice. Free Radical Research, 37(7), 767–772.
82. Mega, C., Teixeira-de-Lemos, E., Fernandes, R., & Reis, F. (2017). Renoprotective effects of the dipeptidyl peptidase-4 inhibitor sitagliptin: A review in type 2 diabetes. Journal of Diabetes Research, 2017, 5164292–14.
83. Mirmiranpour, H., Mousavizadeh, M., Noshad, S., Ghavami, M., Ebadi, M., Ghasemiesfe, M., … Esteghamati, A. (2013). Comparative effects of pioglitazone and metformin on oxidative stress markers in newly diagnosed type 2 diabetes patients: A randomized clinical trial. Journal of Diabetes and its Complications, 27(5), 501–507.
84. Mittler, R. (2002). Oxidative stress, antioxidants and stress tolerance. Trends in Plant Science, 7(9), 405–410.
85. Mittler, R., Vanderauwera, S., Suzuki, N., Miller, G., Tognetti, V. B., Vandepoele, K., … Van Breusegem, F. (2011). ROS signaling: The new wave? Trends in Plant Science, 16(6), 300–309.
86. De Montellano, P. R. O. (2005). Cytochrome P450: Structure, mechanism, and biochemistry. Springer Science & Business Media
87. Morrow, J. D., Hill, K. E., Burk, R. F., Nammour, T. M., Badr, K. F., & Roberts, L. J. (1990). A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proceedings of the National Academy of Sciences, 87(23), 9383–9387.
88. Murakami, K., Takahito, K., Ohtsuka, Y., Fujiwara, Y., Shimada, M., & Kawakami, Y. (1989). Impairment of glutathione metabolism in erythrocytes from patients with diabetes mellitus. Metabolism: Clinical and Experimental, 38(8), 753–758.
89. Nasiry, D., Khalatbary, A. R., & Ahmadvand, H. (2017). Therapeutic potential of Juglans regia L. Leaf extract against diabetic retinopathy in rat. Iranian Journal of Basic Medical Sciences, 20(11), 1275–1281.
90. Nicolls, M. R., Haskins, K., & Flores, S. C. (2007). Oxidant stress, immune dysregulation, and vascular function in type I diabetes. Antioxidants & redox signaling, 9(7), 879–889.
91. Niedowicz, D. M., & Daleke, D. L. (2005). The role of oxidative stress in diabetic complications. Cell Biochemistry and Biophysics, 43(2), 289–330.
92. Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S., Matsumura, T., Kaneda, Y., … Brownlee, M. (2000). Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature, 404(6779), 787–790.
93. Oelze, M., Kröller-Schön, S., Welschof, P., Jansen, T., Hausding, M., Mikhed, Y., … Daiber, A. (2014). The sodium-glucose co-transporter 2 inhibitor empagliflozin improves diabetes-induced vascular dysfunction in the streptozotocin diabetes rat model by interfering with oxidative stress and glucotoxicity. PLOS One, 9(11), e112394.
94. Osorio, H., Coronel, I., Arellano, A., Pacheco, U., Bautista, R., Franco, M., & Escalante, B. (2012). Sodium-glucose cotransporter inhibition prevents oxidative stress in the kidney of diabetic rats. Oxidative Medicine and Cellular Longevity, 2012, 1–7.
95. Oueslati, N., Charradi, K., Bedhiafi, T., Limam, F., & Aouani, E. (2016). Protective effect of grape seed and skin extract against diabetes-induced oxidative stress and renal dysfunction in virgin and pregnant rat. Biomedicine & Pharmacotherapy, 83, 584–592.
96. Panahi, Y., Khalili, N., Sahebi, E., Namazi, S., Karimian, M. S., Majeed, M., & Sahebkar, A. (2017). Antioxidant effects of curcuminoids in patients with type 2 diabetes mellitus: A randomized controlled trial. Inflammopharmacology, 25(1), 25–31.
97. Panahi, Y., Khalili, N., Sahebi, E., Namazi, S., Simental-Mendía, L., Majeed, M., & Sahebkar, A. (2018). Effects of curcuminoids plus piperine on glycemic, hepatic and inflammatory biomarkers in patients with type 2 diabetes mellitus: A randomized double-blind placebo-controlled trial. Drug Research, 68(7), 403–409.
98. Park, S.-H., Choi, H.-J., Lee, J.-H., Woo, C.-H., Kim, J.-H., & Han, H.-J. (2001). High glucose inhibits renal proximal tubule cell proliferation and involves PKC, oxidative stress, and TGF-β1. Kidney International, 59(5), 1695–1705.
99. Parks, D. A., & Granger, D. N. (1986). Xanthine oxidase: Biochemistry, distribution and physiology. Acta Physiologica Scandinavica, Supplementum, 548, 87–99.
100. Raad, H., Paclet, M.-H., Boussetta, T., Kroviarski, Y., Morel, F., Quinn, M. T., … El-Benna, J. (2009). Regulation of the phagocyte NADPH oxidase activity: Phosphorylation of gp91phox/NOX2 by protein kinase C enhances its diaphorase activity and binding to Rac2, p67phox, and p47phox. The FASEB Journal, 23(4), 1011–1022.
101. Rabilloud, T., Heller, M., Rigobello, M. P., Bindoli, A., Aebersold, R., & Lunardi, J. (2001). The mitochondrial antioxidant defence system and its response to oxidative stress. Proteomics, 1(9), 1105–1110.
102. Ramanathan, M., Jaiswal, A. K., & Bhattacharya, S. K. (1999). Superoxide dismutase, catalase and glutathione peroxidase activities in the brain of streptozotocin induced diabetic rats. Indian Journal of Experimental Biology, 37(2), 182–183.
103. Raza, H., Prabu, S. K., John, A., & Avadhani, N. G. (2011). Impaired mitochondrial respiratory functions and oxidative stress in streptozotocin-induced diabetic rats. International Journal of Molecular Sciences, 12(5), 3133–3147.
104. Robertson, G., Leclercq, I., & Farrell, G. C. (2001). II. Cytochrome P-450 enzymes and oxidative stress. American Journal of Physiology-Gastrointestinal and Liver Physiology, 281(5), G1135–G1139.
105. Rochette, L., Zeller, M., Cottin, Y., & Vergely, C. (2014). Diabetes, oxidative stress and therapeutic strategies. Biochimica et Biophysica Acta (BBA)-General Subjects, 1840(9), 2709–2729.
106. Sakai, K., Matsumoto, K., Nishikawa, T., Suefuji, M., Nakamaru, K., Hirashima, Y., … Araki, E. (2003). Mitochondrial reactive oxygen species reduce insulin secretion by pancreatic β-cells. Biochemical and Biophysical Research Communications, 300(1), 216–222.
107. Satoh, M., Fujimoto, S., Haruna, Y., Arakawa, S., Horike, H., Komai, N., … Kashihara, N. (2005). NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy. American Journal of Physiology-Renal Physiology, 288(6), F1144–F1152.
108. Sauer, H., Wartenberg, M., & Hescheler, J. (2001). Reactive oxygen species as intracellular messengers during cell growth and differentiation. Cellular Physiology and Biochemistry, 11(4), 173–186.
109. Scherz-Shouval, R., & Elazar, Z. (2011). Regulation of autophagy by ROS: Physiology and pathology. Trends in Biochemical Sciences, 36(1), 30–38.
110. Schieber, M., & Chandel, N. S. (2014). ROS function in redox signaling and oxidative stress. Current Biology, 24(10), R453–R462.
111. Sedeek, M., Callera, G., Montezano, A., Gutsol, A., Heitz, F., Szyndralewiez, C., … Hébert, R. L. (2010). Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: Implications in type 2 diabetic nephropathy. American Journal of Physiology-Renal Physiology, 299(6), F1348–F1358.
112. Sena, L. A., & Chandel, N. S. (2012). Physiological roles of mitochondrial reactive oxygen species. Molecular Cell, 48(2), 158–167.
113. Serrano, F., & Klann, E. (2004). Reactive oxygen species and synaptic plasticity in the aging hippocampus. Ageing Research Reviews, 3(4), 431–443.
114. Shimojo, N., Ishizaki, T., Imaoka, S., Funae, Y., Fuji, S., & Okuda, K. (1993). Changes in amounts of cytochrome P450 isozymes and levels of catalytic activities in hepatic and renal microsomes of rats with streptozocin-induced diabetes. Biochemical Pharmacology, 46(4), 621–627.
115. Shiu, S. W. M., Xiao, S.-M., Wong, Y., Chow, W.-S., Lam, K. S. L., & Tan, K. C. B. (2014). Carbamylation of LDL and its relationship with myeloperoxidase in type 2 diabetes mellitus. Clinical Science, 126(2), 175–181.
116. Sies, H. (2013). Oxidative stress. Elsevier.
117. Simon, H.-U., Haj-Yehia, A., & Levi-Schaffer, F. (2000). Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis, 5(5), 415–418.
118. Simonian, M. A., Gevorkian, D. M., & Mkhitarian, V. G. (1987). Quantitative changes in Cu, Zn-superoxide dismutase and catalase isolated from the liver of alloxan diabetic rats. Biulleten'eksperimental'noi biologii i meditsiny, 103(3), 306–308.
119. Sindhu, R. K., Koo, J. R., Roberts, C. K., & Vaziri, N. D. (2004). Dysregulation of hepatic superoxide dismutase, catalase and glutathione peroxidase in diabetes: Response to insulin and antioxidant therapies. Clinical and Experimental Hypertension, 26(1), 43–53.
120. Tahara, A., Kurosaki, E., Yokono, M., Yamajuku, D., Kihara, R., Hayashizaki, Y., … Shibasaki, M. (2013). Effects of SGLT2 selective inhibitor ipragliflozin on hyperglycemia, hyperlipidemia, hepatic steatosis, oxidative stress, inflammation, and obesity in type 2 diabetic mice. European Journal of Pharmacology, 715(1-3), 246–255.
121. Takahashi, M. (2015). Glycation of proteins. In Taniguchi, N., Endo, T., Hart, G.W., Seeberger, P.H., Wong, C.-H. (Eds.) Glycoscience: Biology and medicine (pp. 1339–1345). Japan (Tokyo): Springer.
122. Talior, I., Tennenbaum, T., Kuroki, T., & Eldar-Finkelman, H. (2005). PKC-δ-dependent activation of oxidative stress in adipocytes of obese and insulin-resistant mice: Role for NADPH oxidase. American Journal of Physiology-Endocrinology And Metabolism, 288(2), E405–E411.
123. Tomczynska, M., Bijak, M., & Saluk, J. (2016). Metformin−the drug for the treatment of autoimmune diseases; a new use of a known anti-diabetic drug. Current Topics in Medicinal Chemistry, 16(19), 2223–2230.
124. Turkseven, S., Kruger, A., Mingone, C. J., Kaminski, P., Inaba, M., Rodella, L. F., … Abraham, N. G. (2005). Antioxidant mechanism of heme oxygenase-1 involves an increase in superoxide dismutase and catalase in experimental diabetes. American Journal of Physiology-Heart and Circulatory Physiology, 289(2), H701–H707.
125. Vaquero, E. C., Edderkaoui, M., Pandol, S. J., Gukovsky, I., & Gukovskaya, A. S. (2004). Reactive oxygen species produced by NAD(P)H oxidase inhibit apoptosis in pancreatic cancer cells. Journal of Biological Chemistry, 279(33), 34643–34654.
126. Verma, S., Chandra, H., & Banerjee, M. (2016). Cyclooxygenase 1 (COX1) expression in type 2 diabetes mellitus: A preliminary study from north India. Egyptian Journal of Medical Human Genetics, 17(1), 41–45.
127. Wallace, D. C. (1992). Diseases of the mitochondrial DNA. Annual Review of Biochemistry, 61(1), 1175–1212.
128. Wang, Z., Hall, S. D., Maya, J. F., Li, L., Asghar, A., & Gorski, J. C. (2003). Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans. British Journal of Clinical Pharmacology, 55(1), 77–85.
129. Wautier, J. L., Wautier, M. P., Schmidt, A. M., Anderson, G. M., Hori, O., Zoukourian, C., … Brett, J. (1994). Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: A link between surface-associated AGEs and diabetic complications. Proceedings of the National Academy of Sciences, 91(16), 7742–7746.
130. Wautier, M.-P., Chappey, O., Corda, S., Stern, D. M., Schmidt, A. M., & Wautier, J.-L. (2001). Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. American Journal of Physiology-Endocrinology And Metabolism, 280(5), E685–E694.
131. Weihrauch, D., Krolikowski, J. G., Jones, D. W., Zhang, H., & Pritchard, K. A. (2015). Inhibiting myeloperoxidase restores collateralization in ischemic hindlimbs in diabetes. Am Heart Assoc.
132. Wiersma, J. J., Meuwese, M. C., van Miert, J. N., Kastelein, A., Tijssen, J. G., Piek, J. J., & Trip, M. D. (2008). Diabetes mellitus type 2 is associated with higher levels of myeloperoxidase. Medical Science Monitor, 14(8), CR406–CR410.
133. Wolff, S. P., & Dean, R. T. (1987). Glucose autoxidation and protein modification. The potential role of ‘autoxidative glycosylation’in diabetes. Biochemical Journal, 245(1), 243–250.
134. Xia, N., Förstermann, U., & Li, H. (2017). Implication of eNOS uncoupling in cardiovascular disease. Reactive Oxygen Species, 3(7), 38–46.
135. Xu, S., Zhao, Y., Jin, C., Yu, L., Ding, F., Fu, G., & Zhu, J. (2017). PKC/NADPH oxidase are involved in the protective effect of pioglitazone in high homocysteine-induced paracrine dyfunction in endothelial progenitor cells. American Journal of Translational Research, 9(3), 1037–1048.
136. Yan, S. D., Schmidt, A. M., Anderson, G. M., Zhang, J., Brett, J., Zou, Y. S., … Stern, D. (1994). Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. Journal of Biological Chemistry, 269(13), 9889–9897.
137. Yaribeygi, H., Farrokhi, F. R., Rezaee, R., & Sahebkar, A. (2018). Oxidative stress induces renal failure: A review of possible molecular pathways. Journal of Cellular Biochemistry, 119(4), 2990–2998.
138. Yaribeygi, H., Katsiki, N., Behnam, B., Iranpanah, H., & Sahebkar, A. (2018). MicroRNAs and type 2 diabetes mellitus: Molecular mechanisms and the effect of antidiabetic drug treatment. Metabolism: Clinical and Experimental, 87, 48–55.
139. Yaribeygi, H, Mohammadi, M. (2017). Protective effect of crocin on kidney performance in chronic uncontrolled hyperglycemia-induced nephropathy in rat. Journal of Zanjan University of Medical Sciences, 25(109), 36–49.
140. Yaribeygi, H., Mohammadi, M. T., Rezaee, R., & Sahebkar, A. (2018a). Crocin improves renal function by declining Nox-4, IL-18, and p53 expression levels in an experimental model of diabetic nephropathy. Journal of Cellular Biochemistry, 119(7), 6080–6093.
141. Yaribeygi, H., Mohammadi, M. T., Rezaee, R., & Sahebkar, A. (2018b). Fenofibrate improves renal function by amelioration of NOX-4, IL-18, and p53 expression in an experimental model of diabetic nephropathy. Journal of Cellular Biochemistry. https://doi.org/10.1002/jcb.27055
142. Yaribeygi, H., Mohammadi, M. T., & Sahebkar, A. (2018). Crocin potentiates antioxidant defense system and improves oxidative damage in liver tissue in diabetic rats. Biomedicine & Pharmacotherapy, 98, 333–337.
143. Yokoyama, M., & Hirata, K.-I. (2007). Endothelial nitric oxide synthase uncoupling: Is it a physiological mechanism of endothelium-dependent relaxation in cerebral artery. Cardiovascular Research, 73(1), 8–9.
144. Zhao, R., Gao, X., Zhang, T., & Li, X. (2016). Effects of Lycium barbarumpolysaccharide on type 2 diabetes mellitus rats by regulating biological rhythms. Iranian Journal of Basic Medical Sciences, 19(9), 1024–1030.
145. Ziegler, D., Buchholz, S., Sohr, C., Nourooz-Zadeh, J., & Roden, M. (2015). Oxidative stress predicts progression of peripheral and cardiac autonomic nerve dysfunction over 6 years in diabetic patients. Acta Diabetologica, 52(1), 65–72.